Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (271-280 of 605) with videos related to

Pageof 61
Sort By:
Data in Brief|December 22, 2021
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic dataDanielle K Manning, Priyanka Shivdasani, Diane R Koeller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Journal of Food Protection|December 20, 2019
Extension of xMAP Food Allergen Detection Assay To Include SesameChung Y Cho, Katherine O Ivens, William L Nowatzke, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 26, 2013
Distress and the parenting dynamic among BRCA1/2 tested mothers and their partnersDarren Mays, Tiffani A DeMarco, George Luta, et al.
The Breast Journal|July 8, 2019
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendationsMarie E Wood, Judy E Garber, Claudine Isaacs, et al.
American Journal of Human Genetics|September 1, 1996
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2T R Rebbeck, F J Couch, J Kant, et al.
American Journal of Surgery|June 14, 2006
The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapyMehra Golshan, Alex Miron, Asa J Nixon, et al.
Breast Cancer Research and Treatment|May 13, 2023
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2016
The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk WomenYongLi Ji, Tiffany Rounds, Abigail Crocker, et al.
Breast Cancer Research and Treatment|March 1, 2023
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Pageof 61

Showing results (271-280 of 605) with videos related to

Sort By:
Pageof 61
Data in Brief|December 22, 2021
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic dataDanielle K Manning, Priyanka Shivdasani, Diane R Koeller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Journal of Food Protection|December 20, 2019
Extension of xMAP Food Allergen Detection Assay To Include SesameChung Y Cho, Katherine O Ivens, William L Nowatzke, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 26, 2013
Distress and the parenting dynamic among BRCA1/2 tested mothers and their partnersDarren Mays, Tiffani A DeMarco, George Luta, et al.
The Breast Journal|July 8, 2019
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendationsMarie E Wood, Judy E Garber, Claudine Isaacs, et al.
American Journal of Human Genetics|September 1, 1996
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2T R Rebbeck, F J Couch, J Kant, et al.
American Journal of Surgery|June 14, 2006
The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapyMehra Golshan, Alex Miron, Asa J Nixon, et al.
Breast Cancer Research and Treatment|May 13, 2023
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2016
The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk WomenYongLi Ji, Tiffany Rounds, Abigail Crocker, et al.
Breast Cancer Research and Treatment|March 1, 2023
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Pageof 61